SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Eye drops to replace painful injections in AMD patients

24-May-2017 - The University of Birmingham has developed a cell-penetrating peptide it claims could be used to make eye drop versions of age-related macular degeneration drugs currently delivered by injection.

Synlogic takeover secures Mirna’s NASDAQ listing + $40m cash

22-May-2017 - Synlogic has announced it will conduct a reverse merger with failed Mirna Therapeutics, to focus on metabolic and inflammatory diseases and cancer.

Aduro and Merck & Co to test Keytruda and CRS-207 in second cancer study

22-May-2017 - Merck & Co and Aduro Biotech have announced plans to test Keytruda combined with CRS-207 in patients suffering malignant pleural mesothelioma as a result of exposure to asbestos.

Consolidated vaccine sector urgently needs a workforce booster shot, Sanofi

16-May-2017 - Long life-cycles and significant consolidation in the manufacturing space have led to a lack of skilled workers in the vaccine space, says Sanofi Pasteur.

News in brief

Thermo Fisher Scientific Inc to buy Patheon NV for $7.2bn

15-May-2017 - Thermo Fisher Scientific Inc has announced its intention to buy Patheon NV in a deal agreed by both firms’ boards.

Aptar Pharma puts stake in US as it aims to expand

11-May-2017 - Aptar Pharma has acquired 20% of the US-based company, Kali Care, less than two months after inaugurating its first facility outside of France.

Medherant hires Laboratoires Plasto Santé to make ibuprofen pain-patch for trials

09-May-2017 - Ibuprofen patch developer Medherant Ltd. has hired France-based contractor Laboratoires Plasto Santé (LPS) to make the product for clinical trials due to start this year.

BioMarin defends US FDA-approved Brineura’s $702k price tag

04-May-2017 - Brineura's $702,000 (€640,000) a-year price tag reflects production costs and investment in tech used to administer the enzyme replacement therapy to the brain says BioMarin Pharmaceuticals.

BPI Europe 2017

Cost-cutting oral vaccine tech will make Vaxart less reliant on CMO

04-May-2017 - Vaxart says its tablet delivery platform has simplified vaccine production so significantly it may bring manufacturing currently contracted to Lonza back in-house.

Astrazeneca and Pieris team to develop mAb-like drugs for lung diseases

03-May-2017 - Astrazeneca has teamed up with Pieris Pharmaceuticals Inc to develop antibody like mini proteins for the treatment of lung diseases.

H&T Presspart buys rights to Hovione inhaler tech

27-Apr-2017 - H&T Presspart has bought the rights to manufacture and commercialise a capsule-based dry powder inhaler (DPI) from Hovione.

DISPATCHES FROM BPI EUROPE 2017

Messenger RNA a ‘game-changer’ for vaccine industry, Sanofi Pasteur

26-Apr-2017 - Sanofi Pasteur says heavy investment in messenger RNA (mRNA) is warranted as such technology could revolutionise vaccine development and manufacturing.

Wearable drug delivery tech firm Unilife files for Chapter 11 bankruptcy

20-Apr-2017 - Unilife Corporation has filed for Chapter 11 bankruptcy and confirmed that a key customer for its wearable injectors business has halted a project.

Partnering key to deliver next-gen drug delivery tech, say industry experts

19-Apr-2017 - Partnering and collaborating to advance drug delivery innovation  is essential, now more than ever, say industry experts from Boehringer-Ingelheim and Merck.

Cadila and Arecor team to develop longer-acting insulin glargine

13-Apr-2017 - Arecor has entered a £45m ($56m) agreement to develop once daily injection of Cadila Pharmaceuticals’ basal insulin product using its reformulation technology.

Ohr Pharmaceutical says it has funds to complete PhIII eye drug trial

11-Apr-2017 - Ohr Pharmaceutical has raised enough money to complete a Phase III trial of its AMD drug - Squalamine – just days after NASDAQ officials gave it 180 days to regain the exchange’s minimum listing price.

Ferring teams up with Alrise in latest drug delivery tech deal

10-Apr-2017 - Ferring Pharmaceuticals has agreed to help Alrise Biosystems develop its drug delivery technology in its latest encapsulation-focused agreement.

Shire success will support polysialic acid drug delivery platform, says Xenetic

06-Apr-2017 - Xenetic Biosciences says success for Shire’s haemophilia A candidate SHP656 will validate its PolyXen drug delivery technology platform and could net the firm up to $100m.

US FDA accepts Evoke's CMC and PK trial plan for nasal metoclopramide

05-Apr-2017 - The US FDA has accepted a manufacturing and trial plan for Evoke Pharma's Gimoti, the nasal metoclopramide formulation that fell short in a Phase III trial last year.

Mylan pulls Epipens in US on worries about Pfizer-made anaphylaxis jab

03-Apr-2017 - Mylan has recalled batches of its EpiPen in the US over concerns the auto-injector device made by Pfizer’s Meridian Medical Technologies unit is faulty.

Emisphere set to benefit as Novo Nordisk pushes oral diabetes pipeline

30-Mar-2017 - Novo Nordisk’s focus on developing oral versions of semaglutide and four other diabetes drugs could net drug delivery firm Emisphere over $200m.

Alexion licenses mRNA delivery tech from Arbutus in potential $82.5m deal

27-Mar-2017 - Alexion Pharmaceuticals will use the LNP delivery licensed from Arbutus Biopharma as part of its messenger RNA therapeutics development partnership with Moderna Therapeutics.

Compounding firm looks at NDA opportunity for reformulation of Mallinckrodt's H.P. Acthar

23-Mar-2017 - Imprimis Pharmaceuticals says it is evaluating pursuing New Drug Application (NDA) status for some of its product reformulations through the US FDA 505(b)(2) development pathway.

Pulmatrix secures EU patent for dry powder delivery tech

22-Mar-2017 - Pulmatrix Inc has extended its IP portfolio with a European patent for its particle-based drug delivery technology.

update - Epipen manufacturer Meridian Medical Technologies completes investigation

Meda recalls EpiPen batch in Denmark after reports of defects

20-Mar-2017 - Mylan subsidiary Meda has recalled a batch of EpiPens in Denmark after reports some have defective auto-injectors.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...